SCHEDULE 13D/A: Skycrest Boosts Zeo Scientifix Stake to 7.04%
Beneficial Ownership Amendment
Skycrest Holdings, LLC has increased its beneficial ownership in Zeo Scientifix, Inc. to 7.04% through recent open market purchases.
Summary
- Skycrest Holdings, LLC, the Reporting Person, has filed Amendment No. 4 to its Schedule 13D regarding its beneficial ownership in Zeo Scientifix, Inc.
- As of the filing date, Skycrest Holdings, LLC beneficially owns 461,371 shares of Zeo Scientifix, Inc. common stock.
- This ownership represents 7.04% of the Issuer's common stock, based on 6,551,094 shares outstanding as of September 12, 2025.
- The additional shares were acquired through open market purchases funded by the Reporting Person's working capital.
- Recent purchases include transactions on June 6, 2025 (11,100 shares at $2.00), June 9, 2025 (138 shares at $1.99), June 11, 2025 (524 shares at $2.00), June 18, 2025 (3,000 shares at $2.05), June 20, 2025 (1,002 shares at $2.27), June 25, 2025 (6,000 shares at $2.00), and October 16, 2025 (45,000 shares at $2.40).
Sentiment
Score: 7
Explanation: The increase in beneficial ownership by an institutional investor suggests continued confidence in the company, which is generally a positive signal for the market.
Positives
- An institutional investor, Skycrest Holdings, LLC, has increased its stake in Zeo Scientifix, Inc., potentially signaling confidence in the company's future.
- The purchases were made in the open market, indicating a market-based investment decision.
Future Outlook
Skycrest Holdings, LLC currently has no definite plan to acquire or dispose of additional shares of Zeo Scientifix, Inc. common stock, but reserves the right to do so in the future, subject to compliance with applicable securities laws.
Management Comments
- Skycrest Holdings, LLC has no definite plan to acquire or dispose of additional shares of the Issuer's common stock in open market or private transactions, but may do so in the future, subject to compliance with the Exchange Act and the rules and regulations thereunder.
Industry Context
This filing is a specific disclosure of an investor's beneficial ownership and does not provide broader industry trends or competitive analysis for Zeo Scientifix, Inc.
Legal Proceedings
- Skycrest Holdings, LLC has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
- Skycrest Holdings, LLC was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws during the last five years.
Related Party Transactions
- There are no contracts, arrangements, understandings, or relationships (legal or otherwise) between the Reporting Person and any other person with respect to any securities of the Issuer.
Stakeholder Impact
- Increased institutional ownership may signal confidence to other investors, potentially influencing market perception and stock stability.
- Shareholders may view the increased stake as a positive indicator of long-term value.
Next Steps
- Skycrest Holdings, LLC may acquire or dispose of additional shares of Zeo Scientifix, Inc. common stock in the future.
Key Dates
| Date | Description |
|---|---|
| 2018-08-16 | Original Schedule 13D filing date |
| 2023-02-14 | Amendment No. 1 to Schedule 13D filing date |
| 2025-01-07 | Amendment No. 2 to Schedule 13D filing date |
| 2025-05-23 | Amendment No. 3 to Schedule 13D filing date |
| 2025-06-06 | Purchase of 11,100 shares of Common Stock at $2.00 |
| 2025-06-09 | Purchase of 138 shares of Common Stock at $1.99 |
| 2025-06-11 | Purchase of 524 shares of Common Stock at $2.00 |
| 2025-06-18 | Purchase of 3,000 shares of Common Stock at $2.05 |
| 2025-06-20 | Purchase of 1,002 shares of Common Stock at $2.27 |
| 2025-06-25 | Purchase of 6,000 shares of Common Stock at $2.00 |
| 2025-09-12 | Date as of which 6,551,094 shares of common stock were outstanding, as reported in Issuer's 10-Q |
| 2025-09-15 | Date Issuer filed Quarterly Report on Form 10-Q |
| 2025-10-16 | Date of event requiring filing of this statement; last reported purchase of 45,000 shares of Common Stock at $2.40 |
| 2025-10-20 | Signature date of Amendment No. 4 |
Recommendation
holdSkycrest Holdings, LLC's increased beneficial ownership to 7.04% suggests continued confidence in Zeo Scientifix, Inc. However, this Schedule 13D amendment primarily reports ownership changes and does not provide new fundamental data or strategic shifts that would warrant a stronger recommendation. Investors should hold and monitor for further operational or financial updates from the company.
Keywords
Zeo Scientifix, Skycrest Holdings, Schedule 13D, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.